30 Stocks Moving In Monday's Mid-Day Session


Gainers

  • Xenon Pharmaceuticals Inc. XENE shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.
  • Elmira Savings Bank ESBK surged 67.3% to $22.59 after the company announced it would be acquired by Community Bank System.
  • Otonomo Technologies Ltd. OTMO shares gained 22.9% to $6.02.
  • OpGen, Inc. OPGN climbed 19.9% to $3.3050 after the company announced it received FDA clearance for Acuitas AMR gene panel. The company also provided a business update and announced preliminary unaudited revenue and cash position for Q3.
  • U.S. Well Services, Inc. USWS gained 17.5% to $3.0101.
  • AmpliTech Group, Inc. AMPG jumped 15.3% to $4.13. The company announced plans to launch MMIC semiconductor chip design center in Texas.
  • Jasper Therapeutics, Inc. JSPR rose 13.7% to $10.64. Amgen reported a stake of 2.7 million shares in Jasper Therapeutics in a 13G filing on Friday.
  • Adverum Biotechnologies, Inc. ADVM shares rose 12.8% to $2.46 after the company announced new long-term data from the OPTIC clinical trial of ADVM-022 single, in-office intravitreal injection gene therapy in patients requiring frequent anti-VEGF injections for their neovascular or wet age-related macular degeneration.
  • ENGlobal Corporation ENG rose 12.5% to $3.58 after climbing 19% on Friday.
  • Independence Contract Drilling, Inc. ICD gained 11.7% to $3.3741.
  • Farmmi, Inc.. FAMI rose 10.9% to $0.3920 after dipping over 23% on Friday. Farmmi recently issued an update letter, in which it announced the acquisition of Xiangbo for RMB70 million.
  • Salem Media Group, Inc. SALM jumped 9.7% to $4.4450 after gaining 9% on Friday.
  • Teekay LNG Partners L.P. TGP surged 8.4% to $17.01 after Stonepeak announced it will acquire the company in a $6.2 billion transaction.
  • RedHill Biopharma Ltd. RDHL gained 8% to $4.7200 after the company reported further analysis of Phase 2/3 data including a 62% reduction in mortality with oral opaganib in moderately severe COVID-19 patients.
  • Sovos Brands, Inc. SOVO jumped 7.8% to $14.49. The company recently priced its IPO at $12 a share.
  • 4D pharma plc LBPS rose 7.4% to $6.66.
  • Arqit Quantum Inc.. ARQQ rose 6.6% to $19.50 after declining around 9% on Friday.


Check out these big penny stock gainers and losers

Losers

  • Amplify Energy Corp. AMPY shares dipped 41% to $3.3950 following a southern California ocean oil spill from a rig operated by Amplify Energy.
  • Owlet, Inc. OWLT shares tumbled 20.6% to $4.35.
  • Offerpad Solutions Inc. OPAD fell 14.7% to $7.21 after the company, on Friday, announced a mixed shelf offering.
  • REGENXBIO Inc. RGNX dropped 14.2% to $34.56.
  • Danaos Corporation DAC dipped 13.2% to $71.10.
  • Omeros Corporation OMER dropped 12.8% to $7.44. Maxim Group downgraded Omeros from Buy to Hold.
  • Guardforce AI Co., Limited GFAI fell 12.6% to $3.45. Guardforce AI Co., on Friday. announced closing of $15 million underwritten public offering.
  • Biomerica, Inc. BMRA tumbled 11.1% to $5.53 after jumping 38% on Friday. Biomerica recently entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.
  • Silverback Therapeutics, Inc. SBTX fell 11.1% to $10.37 after climbing 17% on Friday.
  • ZIM Integrated Shipping Services Ltd. ZIM dropped 10.9% to $44.15.
  • Sierra Metals Inc. SMTS dropped 9.8% to $2.2001.
  • Nutriband Inc. NTRB fell 9.1% to $6.08. Nutriband's AVERSA Technology received a Notice of Allowance from USPTO for application titled 'Abuse and Misuse Deterrent Transdermal Systems.' The company recently priced $6.6 million public offering at $6.25 per unit.
  • Cyren Ltd. CYRN shares fell 7.1% to $0.5577. CYREN filed for resale of up to 29.2 million ordinary shares.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!